Shared risk or competition for emerging assets: How can we optimise the Pharma-VC relationship?
Co-founder and CEO of Enterome, Pierre brings more than 20 years of successful experience in healthcare companies. Prior to starting Enterome in 2012, Pierre spent 2 years at Sanofi leading Business Development, Licensing and Acquisitions within the Ophthalmology division. He was in 2005 manager in residence at Sofinnova Partners (Paris) where he put in place the business plan, organization, and financing of a new company named Fovea Pharmaceuticals. Pierre has then served as COO of this retinal disease venture that was acquired in 2009 by Sanofi.
Earlier in his career, Pierre held various business or commercial positions in companies like UroGene, Fournier or Ethypharm.
As a biotechnology entrepreneur, he has co-founded several companies including Maat Pharma, Targedys, Monabee, Athena, Cytis, and Opia. Pierre also sits on different company boards. Pierre holds an MBA from INSEAD and a PhD from the University of Paris.